855PD - Docetaxel for hormone-naïve prostate cancer (PCa): Results from long-term follow-up of non-metastatic (M0) patients in the STAMPEDE randomised trial
| Autor: | James, N.D., Ingleby, F.C., Clarke, N.W., Amos, C., Attard, G., Cross, W., Dearnaley, D., Gilbert, D., Jones, R., Langley, R., Mason, M.D., Matheson, D., Parker, C., Ritchie, A., Rush, H.L., Russell, M., Pereira Mestre, R., Parmar, M.K.B., Sydes, M.R. |
|---|---|
| Zdroj: | In Annals of Oncology October 2019 30 Supplement 5:v331-v331 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|